The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent

Transplantation

Volumn 80, Issue 3, 2005, Pages 385-393

  Jonker, Margreet ^a   Danskine, Anna ^c   Haanstra, Krista ^a   Wubben, Jacqueline ^a   Kondova, Ivanela ^a   Kuhn, Eva Maria ^b   Rose, Marlene ^c  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b INTERVET INTERNATIONAL BV   (Netherlands)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Antivimentin antibodies; Experimental transplantation; Histology and anatomy; Immunosuppression (clinical and experimental); Immunosuppression general; Kidney; Morphology; Pathology; Transplantation immunology and immunobiology

Indexed keywords

AUTOANTIGEN; CD3 ANTIBODY; CD40 ANTIBODY; CD40 ANTIGEN; CD86 ANTIBODY; CD86 ANTIGEN; CYCLOSPORIN A; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAPAMYCIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; AUTOPSY; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SERUM; SPLEEN CELL;

ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD86; AUTOIMMUNITY; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIMENTIN;

EID: 23744516089     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000166920.18998.15     Document Type: Article

References (50)

1. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10(1):167.
2. Colvin RB. Chronic allograft nephropathy. N Engl J Med 2003;349(24): 2288.
3. Jurcevk S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001;71(7):886.
4. Rittling SR, Baserga R. Functional analysis and growth factor regulation of the human vimentin promoter. Mol Cell Biol 1987;7(11):3908.
5. Bravo J, Quiroz Y, Pons H, et al. Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition. Kidney Int Suppl 2003;(86):S46.
6. Grone HJ, Weber K, Grone E, et al. Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney. Am J Pathol 1987;129(1):1.
7. Chevalier RL, Goyal S, Kim A, et al. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int 2000;57(3):882.
8. Galli LG, Volpini RA, Costa RS, et al. Tubular cell lesion, albuminuria, and renal albumin handling in rats treated with Adriamycin. Ren Fail 2001;23(5):693.
9. Kobayashi S, Ishida A, Moriya H, et al. Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic changes. J Lab Clin Med 1999; 133(2):134.
10. Kikuchi H, Kawachi H, Ito Y, et al. Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis. Nephrol Dial Transplant 2000; 15(6):799.
11. Nakatsuji S, Yamate J, Sakuma S. Relationship between vimentin ex-pressing renal tubules and interstitial fibrosis in chronic progressive nephropathy in aged rats. Virchows Arch 1998;433(4):359.
12. Mor-Vaknin N, Punturieri A, Sitwala K, Vimentin is secreted by activated macrophages. Nat Cell Biol 2003;5(1):59.
13. Schuurman HJ, Kuhn EM, Jonker M. Chronic rejection in rhesus monkey kidney allografts. Transplant Proc 1997;29(6):2546.
14. Bontrop RE, Otting N, Slierendregt BL, et al. Evolution of major histocompatibility complex polymorphisms and T-cell receptor diversity in primates. Immunol Rev 1995;143:33,
15. Doxiadis GG, Otting N, Antunes SG, et al. Characterization of the ABO blood group genes in macaques: evidence for convergent evolution. Tissue Antigens 1998;51 (4 Pt 1):321.
16. Neuhaus P, Neuhaus R, Wiersema HD, et al. The technique of kidney transplantation in rhesus monkeys. J Med Primatol 1982;11(3):155.
17. Ossevoort MA, Ringers J, Kuhn EM, et al. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Transplantation 1999;68(7):1010.
18. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55(2):713.
19. Jonker M, van de Hout Y, Neuhaus P, et al. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys. Transplantation 1998;66(7):925.
20. Ringers J, Haanstra KG, Kroczek RA, et al. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates. Transplantation 2002; 73(6):862.
21. Jonker M, Ringers J, Ossevoort MA, et al. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys. Transplantation 2002;73(6):874.
22. Haanstra KG, Ringers J, Sick EA, et al. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates. Transplantation 2003;75(5):637.
23. Sumitran-Karuppan S, Tyden G, Reinholt F, et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997;5(4):321.
24. Worthington JE, Martin S, Al-Husseini DM, et al. Posttransplantation production of donor HLA-specifk antibodies as a predictor of renal transplant outcome. Transplantation 2003;75(7):1034.
25. Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002;74(8):1192.
26. Ferry BL, Welsh KI, Dunn MJ, et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl Immunol 1997;5(1):17.
27. Rose ML, Smith J, Dureau G, et al. Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant 2002;21(2):282.
28. Pelletier RP, Hennessy PK, Adams PW, et al. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant 2002;2(10):926.
29. Rose ML. Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease following cardiac transplantation. Ital Heart J 2001;2(Suppl 3):23S.
30. Podor TJ, Singh D, Chindemi P, et al. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem 2002; 277(9):7529.
31. Rose ML. De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system. J Heart Lung Transplant 2004;23(4):385.
32. Miller LW, Granville DJ, Narula J, et al. Apoptosis in cardiac transplant rejection. Cardiol Clin 2001;19(1):141.
33. Ito H, Kasagi N, Shomori K, et al. Apoptosis in the human allografted kidney. Analysis by terminal deoxynudeotidyl transferase-mediated DUTP-biotin nick end labeling. Transplantation 1995;60(8):794.
34. Porter CJ, Ronan JE, Cassidy MJ. fas-fas-ligand antigen expression and its relationship to increased apoptosis in acute renal transplant rejection. Transplantation 2000;69(6):1091.
35. Propato A, Cutrona G, Francavilla V, et al. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med 2001;7(7):807.
36. Barber LD, Whitelegg A, Madrigal A, et al. Detection of vimentin specific autoreactive CD8+ T cells in cardiac transplant recipients. Transplantation 2004 (in press).
37. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997;94(16):8789.
38. Knechtle SJ, Hamawy MM, Hu H, et al. Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation. Immunol Rev 2001;183:205.
39. Kirk AD, Tadaki DK, Celniker A, et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001;72(3):377.
40. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999;5(6):686.
41. Boon L, Brok HP, Bauer J, et al. Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses. J Immunol 2001;167(5):2942.
42. Haegel-Kronenberger H, Haanstra K, Ziller-Remy C, et al. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys. Gene Ther 2004;11(3):241.
43. Azimzadeh AM, Pfeiffer S, Wu GS, et al. Humoral immunity to vimentin is associated with cardiac allograft injury in nonhumen primates and is partially regulated by CD154. Am J Transplant 2004 (in press).
44. Fedoseyeva EV, Tam RC, Popov IA, et al. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996; 61(5):679.
45. Warraich RS, Pomerance A, Stanley A, et al. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 2000;69(8):1609.
46. Dunn MJ, Rose ML, Latif N, et al. Demonstration by western blotting of antiheart antibodies before and after cardiac transplantation. Transplantation 1991;51(4):806.
47. Laguens RP, Argel MI, Chambo JG, et al. Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy. Transplantation 1996;62(2):211.
48. Fang JC, Kinlay S, Behrendt D, et al. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arteriosder Thromb Vasc Biol 2002;22(12):2044.
49. Yasufuku K, Heidler KM, Woods KA, et al. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002;73(4):500.
50. Haque MA, Mizobuchi T, Yasufuku K, et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002;169(3):1542.